Abstract 137P
Background
Recent single-cell DNA sequencing (scDNA-seq) technologies have enabled the parallel investigation of thousands of individual cells. This is required for accurately reconstructing tumour evolution, during which cancer cells acquire a multitude of different genetic alterations. Although the evolutionary analysis of scDNA-seq datasets is complex due to their unique combination of errors and missing data, several methods have been developed to infer single-cell tumour phylogenies by integrating estimates of the false positive and false negative error rates. This integration relies on the assumption that errors are uniformly distributed both within and across cells. However, this assumption does not always hold; error rates depend on sequencing coverage, which is not constant within or across cells in a sequencing experiment due to, e.g., copy-number alterations and the replication status of a cell, limiting the accuracy of existing methods.
Methods
To address this challenge, we developed PHANTOM, a novel single-cell phylogenetic method that integrates raw sequencing read counts into a statistical framework to robustly correct the errors and missing data. PHANTOM includes bootstrapping to correct for high error frequency genomic positions and a fast probabilistic heuristic based on hypothesis testing to distinguish the remaining errors from truly observed genotypes.
Results
We demonstrate the improved accuracy and robustness of our method compared to existing approaches across several simulation settings. To demonstrate its impact, we applied our method to scDNA-seq datasets comprising >25,000 cells from 31 patients with triple-negative breast cancer or high-grade serous ovarian cancer, as well as targeted scDNA-seq from a cohort of 123 patients with acute myeloid leukaemia, revealing more accurate phylogenies consistent with copy-number alterations.
Conclusions
We developed PHANTOM, a novel single-cell phylogenetic method that accurately and robustly infers single-cell tumour phylogenies. We applied PHANTOM to scDNA-seq cancer datasets, revealing its potential to investigate tumour evolution at unprecedented resolution.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Cancer Research UK.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
59P - Identifying blood-based proteomic mediators of cancer-associated cachexia in non-small cell lung cancer in the TRACERx study
Presenter: Rachel Scott
Session: Cocktail & Poster Display session
Resources:
Abstract
61P - Unveiling the distinctive molecular, clinical, and prognostic features of infant acute myeloid leukemia: An analysis study of pediatric AML datasets from the Children's Oncology Group
Presenter: YU TAO
Session: Cocktail & Poster Display session
Resources:
Abstract
62P - Nomogram for predicting lung metastases in patients with papillary thyroid cancer under 55 years old
Presenter: Huiyun Yang
Session: Cocktail & Poster Display session
Resources:
Abstract
64P - Evaluating gene alterations associated with recurrence in oral cavity squamous cell carcinoma
Presenter: Amanda Reyes
Session: Cocktail & Poster Display session
Resources:
Abstract
65P - Multiplex immunofluorescence analysis of LRRC15 and the TME in early-stage lung adenocarcinoma
Presenter: Jessie Woon
Session: Cocktail & Poster Display session
Resources:
Abstract
66P - Molecular profile of triple-negative breast cancer tumours and their association with response to neoadjuvant treatment: A study using next generation sequencing
Presenter: Juan Ramón Berenguer-Marí
Session: Cocktail & Poster Display session
Resources:
Abstract
67P - Multi-institutional evaluation of interrater agreement of biomarker-drug pair rankings based on the ESMO scale for clinical actionability of molecular targets (ESCAT) and sources of discordance
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
68P - ESR1 gene mutation in hormone receptor (HR)-positive metastatic breast cancers: An NGS-based exploratory study on Indian population
Presenter: Siddappa Shanthala
Session: Cocktail & Poster Display session
Resources:
Abstract
69P - Next generation sequencing in colorectal cancer: Association of BRAF, KRAS mutations with right sided cancers, mucinous disease, lymphovascular/perineural invasion and microsatellite instability
Presenter: Gurpreet Singh Ranger
Session: Cocktail & Poster Display session
Resources:
Abstract
70P - Increased expression of interleukin-17 receptor A (IL-17RA) promotes cancer stem-like properties, resistance to 5-fluorouracil, and the expression of ATP-binding cassette transporters in colorectal cancer cells
Presenter: Chih-Yung Yang
Session: Cocktail & Poster Display session
Resources:
Abstract